Elevated macrophage inflammatory protein 1α and interleukin-17 production in an experimental asthma model infected with respiratory syncytial virus

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 129-137

  Ishioka, Taisei ^c   Yamada, Yoshiyuki ^a   Kimura, Hirokazu ^d   Yoshizumi, Masakazu ^c   Tsukagoshi, Hiroyuki ^c   Kozawa, Kunihisa ^c   Maruyama, Kenichi ^b   Hayashi, Yasuhide ^a   Kato, Masahiko ^a  

^a Gunma Children's Medical Center   (Japan)

^b Department of Nephrology ^*  (Japan)

^c GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Cytokines; Eosinophils; Mice; Respiratory syncytial virus

Indexed keywords

ALLERGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHACHOLINE CHLORIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD ANALYSIS; BODY WEIGHT; CELL INFILTRATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; DISEASE EXACERBATION; EOSINOPHIL; EXPERIMENTAL ASTHMA; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LUNG LAVAGE; LUNG RESISTANCE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TISSUE CULTURE; ANIMAL; ARTICLE; ASTHMA; BIOSYNTHESIS; BLOOD; CELL LINE; CYTOLOGY; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROLOGY;

ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CHEMOKINE CCL3; CYTOKINES; IMMUNOGLOBULIN E; INTERLEUKIN-17; LUNG; MALE; MICE; OVALBUMIN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

MLCS; MLOWN;

EID: 84880560370     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350427     Document Type: Conference Paper

References (43)

1. Lemanske RF: Viral infections and asthma inception. J Allergy Clin Immunol 2004; 114: 1023-1026.
2. Black CP: Systematic review of the biology and medical management of respiratory syn-cytial virus infection. Respir Care 2003; 48: 209-233.
3. Gleich GJ: Mechanisms of eosinophil-associ-ated inflammation. J Allergy Clin Immunol 2000; 105:651-663.
4. Kato M, Abraham RT, Kita H: Tyrosine phos-phorylation is required for eosinophil de-granulation induced by immobilized immu-noglobulins. J Immunol 1995; 155:357-366.
5. Horie S, Gleich GJ, Kita H: Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996; 98:371-381.
6. Fujiu T, Kato M, Kimura H, Tachibana A, Suzuki M, Nako Y, Morikawa A: Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors. Ann Allergy Asthma Immunol 2002; 89: 90-98.
7. Takizawa T, Kato M, Kimura H, Suzuki M, Tachibana A, Obinata H, Izumi T, Tokuyama K, Morikawa A: Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. J Allergy Clin Immunol 2002; 110:241-248.
8. Kato M, Suzuki M, Hayashi Y, Kimura H: Role of eosinophils and their clinical significance on allergic inflammation. Expert Rev Clin Immunol 2006; 2:121-133.
9. Siegle JS, Hansbro N, Herbert C, Rosenberg HF, Domachowske JB, Asquith KL, Foster PS, Kumar RK: Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Resp Res 2010; 11: 14.
10. Domachowske JB, Bonville CA, Rosenberg HF: Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004; 23:S228-S234.
11. Schwarze J, Hamelmann E, Bradley KL, Take-da K, Gelfand EW: Respiratory syncytial virus infection results in airway hyperresponsive-ness and enhanced airway sensitization to allergen. J Clin Invest 1997; 100:226-233.
12. Ishioka T, Kimura H, Kita H, Obuchi M, Hoshino H, Noda M, Nishina A, Kozawa K, Kato M: Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549). Cell Biol Int 2011; 35:467-474.
13. Kato M, Ishioka T, Kita H, Kozawa K, Hayashi Y, Kimura H: Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus. Int Arch Allergy Immunol 2012; 158(suppl 1):11-18.
14. Mäkelä MJ, Kanehiro A, Dakhama A, Borish L, Joetham A, Tripp R, Anderson L, Gelfand EW: The failure of interleukin-10-deficient mice to develop airway hyperresponsive-ness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med 2002; 165:824-831.
15. Kaufman GN, Massoud AH, Audusseau S, Banville-Langelier AA, Wang Y, Guay J, Garellek JA, Mourad W, Piccirillo CA, Mc-Cusker C, Mazer BD: Intravenous immuno-globulin attenuates airway hyperresponsive-ness in a murine model of allergic asthma. Clin Exp Allergy 2011; 41:718-728.
16. Kato M, Yamada Y, Maruyama K, Hayashi Y: Differential effects of corticosteroids on serum eosinophil cationic protein and cytokine production in rhinovirus-and RS virus-induced acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2011; 155 (suppl 1):77-84.
17. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locks-ley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183:109-117.
18. Hamelmann E, Oshiba A, Schwarze J, Bradley K, Loader J, Larsen GL, Gelfand EW: Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 1997; 16:674-682.
19. Wang J, Palmer K, Lotvall J, Milan S, Lei XF, Matthaei KI, Gauldie J, Inman MD, Jordana M, Xing Z: Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998; 102:1132-1141.
20. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Cor-ry DB: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282:2261-2263.
21. Aeffner F, Davis IC. Respiratory syncytial virus reverses airway hyperresponsiveness to methacholine in ovalbumin-sensitized mice. PLoS One 2012; 7:e46660.
22. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman MH, Cybulsky M, Gutierrez-Ramos JC: Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996; 98: 2332-2345.
23. Matsuse H, Behera AK, Kumar M, Rabb H, Lockey RF, Mohapatra SS: Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol 2000; 164:6583-6592.
24. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O: Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hy-perresponsiveness in mice. J Infect Dis 2004; 189:1856-1865
25. Al-Ramli W, Préfontaine D, Chouiali F, Martin JG, Olivenstein R, Lemière C, Hamid Q: T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123:1185-1187.
26. Bera MM, Lu B, Martin TR, Cui S, Rhein LM, Gerard C, Gerard NP: Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol 2011; 187:4245-4255.
27. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW: IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011; 179: 248-258.
28. Panuska JR, Merolla R, Rebert NA, Hoffmann SP, Tsivitse P, Cirino NM, Silverman RH, Rankin JA: Respiratory syncytial virus induces interleukin-10 by human alveolar macro-phages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 1995; 96:2445-2453.
29. Hussell T, Spender LC, Georgiou A, O'Garra A, Openshaw PJ: Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 1996; 77:2447-2455.
30. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney NP, Schuijs M, O'Garra A, Johansson C, Openshaw PJ: IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One 2012; 7:e32371.
31. Borish L: IL-10: evolving concepts. J Allergy Clin Immunol 1998: 101:293-297.
32. Zuany-Amorim C, Hailé S, Leduc D, Duma-rey C, Huerre M, Vargaftig BB, Pretolani M: Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95:2644-2651.
33. Yang X, Wang S, Fan Y, Han X: IL-10 deficiency prevents IL-5 overproduction and eo-sinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 2000; 30: 382-391.
34. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S: Interleukin-10 regulation in normal and asthmatic subjects. J Allergy Clin Immunol 1996; 97:1288-1296.
35. Ohkawara Y, Lei XF, Stämpfli MR, Marshall JS, Xing Z, Jordana M: Cytokine and eosino-phil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997; 16:510-520.
36. Barends M, Boelen A, de Rond L, Kwakkel J, Bestebroer T, Dormans J, Neijens H, Kimman T: Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice. Clin Exp Allergy 2002; 32:463-471.
37. Gavett SH, O'Hearn DJ, Li X, Huang SK, Fin-kelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperrespon-siveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995; 182: 1527-1536.
38. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
39. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995; 154:116-127.
40. Gately MK, Carvajal DM, Connaughton SE, Gillessen S, Warrier RR, Kolinsky KD, Wilkinson VL, Dwyer CM, Higgins GF Jr, Podlaski FJ, Faherty DA, Familletti PC, Stern AS, Presky DH: Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodi-mer in vitro and in vivo. Ann NY Acad Sci 1996; 795:1-12.
41. Shimozato O, Ugai S, Chiyo M, Takenobu H, Nagakawa H, Wada A, Kawamura K, Yama-moto H, Tagawa M: The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 2006; 117: 22-28.
42. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K: Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 1996; 93: 9085-9089.
43. Chen L, Chen D, Block E, O'Donnell M, Kufe DW, Clinton SK. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol 1997; 159:351-359.